1. (a) In this part the following words have the meanings indicated.

2. (b) “Adult stem cell” means a stem cell that is:

   1. (1) derived from human tissue; and
   2. (2) obtained after birth.
3. (c) “Commission” means the Stem Cell Research Commission.
4. (d) “Committee” means the independent scientific peer review committee that contracts with the Commission under § 10-436 of this subtitle.
5. (e) “Fund” means the Maryland Stem Cell Research Fund established under § 10-434 of this subtitle.
6. (f) “Human cloning” means the replication of a human being through the production of a precise genetic copy of nuclear human DNA or any other human molecule, cell, or tissue in order to create a new human being or to allow development beyond an embryo.
7. (g) “Institutional review board” has the meaning stated in the federal regulations on the protection of human subjects.
8. (h) “Oocyte” means a female germ cell or egg.

9. (i) “State-funded stem cell research” means stem cell research conducted with State money and using:

   1. (1) material obtained in accordance with § 10-438 of this subtitle; or
   2. (2) adult stem cells.

10. (j) “Stem cell” means a human cell that has the ability to:

    1. (1) divide indefinitely;
    2. (2) give rise to many other types of specialized cells; and
    3. (3) give rise to new stem cells with identical potential.
11. (k) “Valuable consideration” means financial gain or advantage in connection with material obtained in accordance with § 10-438 of this subtitle.

Added by Acts 2008, c. 306, § 2, eff. Oct. 1, 2008. Amended by Acts 2020, c. 580, § 1, eff. Oct. 1, 2020.